The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
In the test, the chemicals leaching off of the device are compared with a searchable database that provides background on toxicity and the Cramer classification. The proposed change in the standard ...
Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
DUBLIN--(BUSINESS WIRE)--The "Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035" report has been added to ResearchAndMarkets.com's offering. This ...
New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results